Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Your confirmation email is on its way. Please check your inbox for further instructions.

Arteris, Inc. (NASDAQ:AIP) Short Interest Update

→ Warren Buffett's "mystery stock" (From Stansberry Research) (Ad)

Arteris, Inc. (NASDAQ:AIP - Get Free Report) was the target of a large decrease in short interest in April. As of April 15th, there was short interest totalling 188,200 shares, a decrease of 16.2% from the March 31st total of 224,700 shares. Approximately 0.8% of the shares of the stock are sold short. Based on an average daily volume of 148,700 shares, the days-to-cover ratio is presently 1.3 days.

Insider Buying and Selling

In other Arteris news, VP Paul L. Alpern sold 11,250 shares of the firm's stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $6.13, for a total value of $68,962.50. Following the sale, the vice president now owns 87,521 shares in the company, valued at $536,503.73. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other Arteris news, VP Paul L. Alpern sold 11,250 shares of the company's stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $6.13, for a total value of $68,962.50. Following the completion of the transaction, the vice president now owns 87,521 shares of the company's stock, valued at approximately $536,503.73. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CFO Nicholas B. Hawkins sold 10,000 shares of the stock in a transaction dated Thursday, April 11th. The shares were sold at an average price of $7.22, for a total value of $72,200.00. Following the completion of the transaction, the chief financial officer now owns 252,896 shares of the company's stock, valued at $1,825,909.12. The disclosure for this sale can be found here. Insiders sold a total of 80,264 shares of company stock worth $558,958 in the last three months. 36.10% of the stock is owned by corporate insiders.


Hedge Funds Weigh In On Arteris

Hedge funds and other institutional investors have recently bought and sold shares of the company. Victory Capital Management Inc. acquired a new stake in Arteris during the 4th quarter worth about $60,000. Ibex Investors LLC bought a new stake in Arteris in the third quarter worth approximately $99,000. Barclays PLC acquired a new position in Arteris in the third quarter valued at approximately $120,000. Algert Global LLC bought a new position in shares of Arteris during the 3rd quarter worth approximately $142,000. Finally, Worth Venture Partners LLC boosted its holdings in shares of Arteris by 22.6% during the 3rd quarter. Worth Venture Partners LLC now owns 51,301 shares of the company's stock worth $334,000 after buying an additional 9,448 shares in the last quarter. Institutional investors and hedge funds own 64.36% of the company's stock.

Analyst Upgrades and Downgrades

Separately, Wedbush restated an "outperform" rating and issued a $17.00 price target on shares of Arteris in a research report on Tuesday, February 20th.

View Our Latest Stock Report on AIP

Arteris Trading Down 0.9 %

Shares of AIP stock traded down $0.06 on Friday, hitting $6.70. The company had a trading volume of 82,279 shares, compared to its average volume of 88,758. Arteris has a twelve month low of $3.66 and a twelve month high of $8.08. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.26 and a current ratio of 1.26. The firm has a market cap of $257.08 million, a P/E ratio of -6.44 and a beta of 1.03. The stock's 50-day moving average is $6.97 and its two-hundred day moving average is $6.16.

Arteris (NASDAQ:AIP - Get Free Report) last announced its earnings results on Tuesday, February 20th. The company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.01). Arteris had a negative net margin of 68.70% and a negative return on equity of 150.71%. The company had revenue of $12.50 million during the quarter, compared to the consensus estimate of $11.90 million. On average, equities research analysts anticipate that Arteris will post -0.9 earnings per share for the current fiscal year.

About Arteris

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Featured Articles

Should you invest $1,000 in Arteris right now?

Before you consider Arteris, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.

While Arteris currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Featured Articles and Offers

Search Headlines: